Murine models for pharmacological studies of the metabolic syndrome

Pharmacology and Therapeutics

Volumn 137, Issue 3, 2013, Pages 331-340

  Fellmann, Lyne ^a   Nascimento, Alessandro R ^b   Tibiriça, Eduardo ^b   Bousquet, Pascal ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Animal models; High fat diet; Keywords; Leptin; Metabolic syndrome

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; CHOLESTEROL; INSULIN; LEPTIN; LEPTIN RECEPTOR; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADRENERGIC SYSTEM; ALTERNATIVE RNA SPLICING; ARTERIAL PRESSURE; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 2; CHROMOSOME 6; CONGESTIVE HEART FAILURE; DIET THERAPY; DISEASE MODEL; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENERGY EXPENDITURE; ESSENTIAL HYPERTENSION; FOOD INTAKE; GENETIC PREDISPOSITION; GLUCAGON RELEASE; GLUCOSE INTOLERANCE; HEART FAILURE; HYPERINSULINEMIA; HYPOTHALAMUS; INSULIN RELEASE; INSULIN RESISTANCE; LIPID DIET; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS FUNCTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SPONTANEOUS MUTATION; STOP CODON; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; HUMANS; LEPTIN; METABOLIC SYNDROME X; RECEPTORS, LEPTIN;

EID: 84874115254     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.11.004     Document Type: Review

References (218)

1. M. Abe, T. Toyohara, A. Ishii, T. Suzuki, N. Noguchi, and Y. Akiyama The HMG-CoA reductase inhibitor pravastatin stimulates insulin secretion through organic anion transporter polypeptides Drug Metab Pharmacokinet 25 3 2010 274 282
2. A. Agouni, A.H. Lagrue-Lak-Hal, H.A. Mostefai, A. Tesse, P. Mulder, and P. Rouet Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa) PLoS One 4 5 2009 e5557
3. C.A. Aguilar-Salinas, R. Rojas, F.J. Gomez-Perez, R. Mehta, A. Franco, and G. Olaiz The metabolic syndrome: a concept hard to define Arch Med Res 36 3 2005 223 231
4. R.S. Ahima, D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, and E. Maratos-Flier Role of leptin in the neuroendocrine response to fasting Nature 382 6588 1996 250 252
5. B. Ahren, and P.J. Havel Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells) Am J Physiol 277 4 Pt 2 1999 R959 R966
6. A. Ait-Omar, M. Monteiro-Sepulveda, C. Poitou, M. Le Gall, A. Cotillard, and J. Gilet GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice Diabetes 60 10 2011 2598 2607
7. K.A. Al-Barazanji, J.R. Arch, R.E. Buckingham, and M. Tadayyon Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats Obes Res 8 4 2000 317 323
8. N.L. Alderson, M.E. Chachich, N.N. Youssef, R.J. Beattie, M. Nachtigal, and S.R. Thorpe The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats Kidney Int 63 6 2003 2123 2133
9. M. Alonso-Galicia, M.W. Brands, D.H. Zappe, and J.E. Hall Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity Hypertension 28 6 1996 1047 1054
10. K.M. Anderson, A.D. Eckhart, R.N. Willette, and W.J. Koch The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats Hypertension 33 1 Pt 2 1999 402 407
11. L.L. Atkinson, C. McDonald-Dyck, C. Benkoczi, and D.T. Finegood Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats Diabetes Obes Metab 10 9 2008 780 790
12. C.J. Bailey, and P.R. Flatt Adrenoceptor-mediated control of glucose homeostasis in obese hyperglycaemic (ob/ob) mice Diabetes Res 14 2 1990 87 91
13. S.H. Bates, R.N. Kulkarni, M. Seifert, and M.G. Myers Jr. Roles for leptin receptor/STAT3-dependent and -independent signals in the regulation of glucose homeostasis Cell Metab 1 3 2005 169 178
14. S.H. Bates, W.H. Stearns, T.A. Dundon, M. Schubert, A.W. Tso, and Y. Wang STAT3 signalling is required for leptin regulation of energy balance but not reproduction Nature 421 6925 2003 856 859
15. C. Bing, P. King, L. Pickavance, M. Brown, D. Ziegler, and E. Kaan The effect of moxonidine on feeding and body fat in obese Zucker rats: role of hypothalamic NPY neurones Br J Pharmacol 127 1 1999 35 42
16. C.L. Brand, E.D. Galsgaard, D. Tornehave, J. Romer, C.F. Gotfredsen, and K. Wassermann Synergistic effect of the human GLP-1 analogue liraglutide and a dual PPARalpha/gamma agonist on glycaemic control in Zucker diabetic fatty rats Diabetes Obes Metab 11 8 2009 795 803
17. J. Buchanan, P.K. Mazumder, P. Hu, G. Chakrabarti, M.W. Roberts, and U.J. Yun Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity Endocrinology 146 12 2005 5341 5349
18. R. Buettner, K.G. Parhofer, M. Woenckhaus, C.E. Wrede, L.A. Kunz-Schughart, and J. Scholmerich Defining high-fat-diet rat models: metabolic and molecular effects of different fat types J Mol Endocrinol 36 3 2006 485 501
19. M.C. Camus, R. Aubert, F. Bourgeois, J. Herzog, A. Alexiu, and D. Lemonnier Serum lipoprotein and apolipoprotein profiles of the genetically obese ob/ob mouse Biochim Biophys Acta 961 1 1988 53 64
20. M.C. Carmona, K. Louche, M. Nibbelink, B. Prunet, A. Bross, and M. Desbazeille Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice Int J Obes (Lond) 29 7 2005 864 871
21. H. Chen, O. Charlat, L.A. Tartaglia, E.A. Woolf, X. Weng, and S.J. Ellis Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice Cell 84 3 1996 491 495
22. B. Chen, A. Moore, L.V. Escobedo, M.S. Koletsky, D. Hou, and R.J. Koletsky Sitagliptin lowers glucagon and improves glucose tolerance in prediabetic obese SHROB rats Exp Biol Med (Maywood) 236 3 2011 309 314
23. A. Chicco, M.E. D'Alessandro, L. Karabatas, C. Pastorale, J.C. Basabe, and Y.B. Lombardo Muscle lipid metabolism and insulin secretion are altered in insulin-resistant rats fed a high sucrose diet J Nutr 133 1 2003 127 133
24. J. Chidambaram, and A. Carani Venkatraman Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet Food Chem Toxicol 48 8-9 2010 2021 2029
25. I. Chinen, M. Shimabukuro, K. Yamakawa, N. Higa, T. Matsuzaki, and K. Noguchi Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats Endocrinology 148 1 2007 160 165
26. S. Chiu, J.S. Fisler, G.M. Espinal, P.J. Havel, J.S. Stern, and C.H. Warden The yellow agouti mutation alters some but not all responses to diet and exercise Obes Res 12 8 2004 1243 1255
27. C. Chlouverakis, E.F. Dade, and R.A. Batt Glucose tolerance and time sequence of adiposity, hyperinsulinemia and hyperglycemia in obese-hyperglycemic mice (obob) Metabolism 19 9 1970 687 693
28. S.H. Choi, Z.S. Zhao, Y.J. Lee, S.K. Kim, D.J. Kim, and C.W. Ahn The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats Diabetes Metab Res Rev 23 5 2007 411 418
29. S. Cipriani, A. Mencarelli, G. Palladino, and S. Fiorucci FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats J Lipid Res 51 4 2010 771 784
30. A. Cittadini, R. Napoli, M.G. Monti, D. Rea, S. Longobardi, and P.A. Netti Metformin prevents the development of chronic heart failure in the SHHF rat model Diabetes 61 4 2012 944 953
31. M.P. Cleary, B. Kasiske, M.P. O'Donnell, and W.F. Keane Effect of long-term clofibric acid treatment on serum and tissue lipid and cholesterol levels in obese Zucker rats Atherosclerosis 66 1-2 1987 107 112
32. G. Coatmellec-Taglioni, J.P. Dausse, Y. Giudicelli, and C. Ribiere Gender difference in diet-induced obesity hypertension: implication of renal alpha2-adrenergic receptors Am J Hypertens 15 2 Pt 1 2002 143 149
33. D.L. Coleman Effects of parabiosis of obese with diabetes and normal mice Diabetologia 9 4 1973 294 298
34. D.L. Coleman, and K.P. Hummel Studies with the mutation, diabetes, in the mouse Diabetologia 3 2 1967 238 248
35. D.L. Coleman, and K.P. Hummel The influence of genetic background on the expression of the obese (Ob) gene in the mouse Diabetologia 9 4 1973 287 293
36. E. Colle, R.D. Guttmann, and T. Seemayer Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex J Exp Med 154 4 1981 1237 1242
37. S. Collins, C.M. Kuhn, A.E. Petro, A.G. Swick, B.A. Chrunyk, and R.S. Surwit Role of leptin in fat regulation Nature 380 6576 1996 677
38. M.L. Correia, W.G. Haynes, K. Rahmouni, D.A. Morgan, W.I. Sivitz, and A.L. Mark The concept of selective leptin resistance: evidence from agouti yellow obese mice Diabetes 51 2 2002 439 442
39. I. Cusin, F. Rohner-Jeanrenaud, A. Stricker-Krongrad, and B. Jeanrenaud The weight-reducing effect of an intracerebroventricular bolus injection of leptin in genetically obese fa/fa rats. Reduced sensitivity compared with lean animals Diabetes 45 10 1996 1446 1450
40. D.B. Dal Ponte, D.L. Fogt, S. Jacob, and E.J. Henriksen Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance Metabolism 47 8 1998 982 987
41. X. Ding, N.K. Saxena, S. Lin, N.A. Gupta, and F.A. Anania Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice Hepatology 43 1 2006 173 181
42. J. Divisova, L. Kazdova, M. Hubova, and E. Meschisvili Relationship between insulin resistance and muscle triglyceride content in nonobese and obese experimental models of insulin resistance syndrome Ann N Y Acad Sci 967 2002 440 445
43. A.D. Dobrian, M.J. Davies, R.L. Prewitt, and T.J. Lauterio Development of hypertension in a rat model of diet-induced obesity Hypertension 35 4 2000 1009 1015
44. J.H. Dominguez, P. Wu, J.W. Hawes, M. Deeg, J. Walsh, and S.C. Packer Renal injury: similarities and differences in male and female rats with the metabolic syndrome Kidney Int 69 11 2006 1969 1976
45. E.F. du Toit, M. Nabben, and A. Lochner A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury Basic Res Cardiol 100 4 2005 346 354
46. K.L. Ellacott, J.G. Murphy, D.L. Marks, and R.D. Cone Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling Endocrinology 148 12 2007 6186 6194
47. V. Emilsson, Y.L. Liu, M.A. Cawthorne, N.M. Morton, and M. Davenport Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion Diabetes 46 2 1997 313 316
48. P. Ernsberger, J.L. Johnson, T. Rosenthal, D. Mirelman, and R.J. Koletsky Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome Am J Hypertens 20 8 2007 866 874
49. P. Ernsberger, R.J. Koletsky, J.S. Baskin, and M. Foley Refeeding hypertension in obese spontaneously hypertensive rats Hypertension 24 6 1994 699 705
50. P. Ernsberger, R.J. Koletsky, L.A. Collins, and D. Bedol Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent Cardiovasc Drugs Ther 10 Suppl. 1 1996 275 282
51. P. Ernsberger, R.J. Koletsky, and J.E. Friedman Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X Ann N Y Acad Sci 892 1999 272 288
52. W. Fan, B.A. Boston, R.A. Kesterson, V.J. Hruby, and R.D. Cone Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385 6612 1997 165 168
53. W. Fan, D.M. Dinulescu, A.A. Butler, J. Zhou, D.L. Marks, and R.D. Cone The central melanocortin system can directly regulate serum insulin levels Endocrinology 141 9 2000 3072 3079
54. H. Fei, H.J. Okano, C. Li, G.H. Lee, C. Zhao, and R. Darnell Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues Proc Natl Acad Sci U S A 94 13 1997 7001 7005
55. F. Forcheron, A. Basset, P. Del Carmine, and M. Beylot Lipase maturation factor 1: its expression in Zucker diabetic rats, and effects of metformin and fenofibrate Diabetes Metab 35 6 2009 452 457
56. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 6704 1998 763 770
57. H. Fujita, H. Fujishima, J. Koshimura, M. Hosoba, N. Yoshioka, and T. Shimotomai Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice Endocr J 52 4 2005 427 433
58. A. Funakoshi, K. Miyasaka, A. Jimi, T. Kawanai, Y. Takata, and A. Kono Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty = OLETF rats) Biochem Biophys Res Commun 199 2 1994 482 488
59. A. Funakoshi, K. Miyasaka, H. Shinozaki, M. Masuda, T. Kawanami, and Y. Takata An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor Biochem Biophys Res Commun 210 3 1995 787 796
60. B.R. Gedulin, S.E. Nikoulina, P.A. Smith, G. Gedulin, L.L. Nielsen, and A.D. Baron Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight Endocrinology 146 4 2005 2069 2076
61. D. Gomez-Garre, M.L. Gonzalez-Rubio, P. Munoz-Pacheco, A. Caro-Vadillo, P. Aragoncillo, and A. Fernandez-Cruz Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction Eur J Heart Fail 12 9 2010 903 912
62. A.C. Goncalves, J. Tank, A. Diedrich, A. Hilzendeger, R. Plehm, and M. Bader Diabetic hypertensive leptin receptor-deficient db/db mice develop cardioregulatory autonomic dysfunction Hypertension 53 2 2009 387 392
63. A.G. Goodwill, S.J. Frisbee, P.A. Stapleton, M.E. James, and J.C. Frisbee Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome Microcirculation 16 8 2009 667 684
64. O. Grisk, T. Frauendorf, T. Schluter, I. Kloting, B. Kuttler, and A. Krebs Impaired coronary function in Wistar Ottawa Karlsburg W rats - a new model of the metabolic syndrome Pflugers Arch 454 6 2007 1011 1021
65. M.L. Gruen, M.R. Plummer, W. Zhang, K.A. Posey, M.F. Linton, and S. Fazio Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I J Lipid Res 46 9 2005 2007 2014
66. A. Handberg, L. Kayser, P.E. Hoyer, M. Voldstedlund, H.P. Hansen, and J. Vinten Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats Diabetologia 36 6 1993 481 486
67. C.T. Hansen two new congenic strains for nutrition and obesity research Fed Proc Fed Am Soc Exp Biol 42 1983 537
68. M.R. Hayes, S.E. Kanoski, A.L. Alhadeff, and H.J. Grill Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats Obesity (Silver Spring) 19 7 2011 1342 1349
69. D.A. Hems, E.A. Rath, and T.R. Verrinder Fatty acid synthesis in liver and adipose tissue of normal and genetically obese (ob/ob) mice during the 24-hour cycle Biochem J 150 2 1975 167 173
70. E.J. Henriksen, S. Jacob, D.L. Fogt, E.B. Youngblood, and J. Godicke Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats Hypertension 30 6 1997 1560 1565
71. J.R. Heyen, E.R. Blasi, K. Nikula, R. Rocha, H.A. Daust, and G. Frierdich Structural, functional, and molecular characterization of the SHHF model of heart failure Am J Physiol Heart Circ Physiol 283 5 2002 H1775 H1784
72. K.P. Hummel, M.M. Dickie, and D.L. Coleman Diabetes, a new mutation in the mouse Science 153 740 1966 1127 1128
73. D. Huszar, C.A. Lynch, V. Fairchild-Huntress, J.H. Dunmore, Q. Fang, and L.R. Berkemeier Targeted disruption of the melanocortin-4 receptor results in obesity in mice Cell 88 1 1997 131 141
74. M. Iida, T. Murakami, K. Ishida, A. Mizuno, M. Kuwajima, and K. Shima Phenotype-linked amino acid alteration in leptin receptor cDNA from Zucker fatty (fa/fa) rat Biochem Biophys Res Commun 222 1 1996 19 26
75. M. Iida, T. Murakami, K. Ishida, A. Mizuno, M. Kuwajima, and K. Shima Substitution at codon 269 (glutamine → proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat Biochem Biophys Res Commun 224 2 1996 597 604
76. S. Ikemoto, M. Takahashi, N. Tsunoda, K. Maruyama, H. Itakura, and O. Ezaki High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils Metabolism 45 12 1996 1539 1546
77. A.M. Ingalls, M.M. Dickie, and G.D. Snell Obese, a new mutation in the house mouse J Hered 41 12 1950 317 318
78. K. Ishida, A. Mizuno, Z. Min, T. Sano, and K. Shima Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non-insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion? Metabolism 44 7 1995 940 945
79. N. Ishizaka, M. Hongo, G. Matsuzaki, K. Furuta, K. Saito, and R. Sakurai Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome Hypertens Res 33 3 2010 263 268
80. T. Ishizuka, P. Ernsberger, S. Liu, D. Bedol, T.M. Lehman, and R.J. Koletsky Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB) J Nutr 128 12 1998 2299 2306
81. M. Ivanova, P. Janega, J. Matejikova, P. Simoncikova, D. Pancza, and T. Ravingerova Activation of Akt kinase accompanies increased cardiac resistance to ischemia/reperfusion in rats after short-term feeding with lard-based high-fat diet and increased sucrose intake Nutr Res 31 8 2011 631 643
82. S. Jacob, D.L. Fogt, G.J. Dietze, and E.J. Henriksen The beta2-adrenergic modulator celiprolol reduces insulin resistance in obese Zucker rats Life Sci 64 22 1999 2071 2079
83. P. Janiak, J.P. Bidouard, C. Cadrouvele, B. Poirier, L. Gouraud, and Y. Grataloup Long-term blockade of angiotensin AT1 receptors increases survival of obese Zucker rats Eur J Pharmacol 534 1-3 2006 271 279
84. S. Jesmin, I. Sakuma, Y. Hattori, A. Kitabatake, and T. Miyauchi The calcium channel antagonist benidipine reduces plasma and cardiac endothelin-1 levels in type II diabetic rat model J Cardiovasc Pharmacol 44 Suppl. 1 2004 S49 S53
85. D. Jia, M. Yamamoto, M. Otani, and M. Otsuki Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats Metabolism 53 4 2004 405 413
86. V. Jindal, D. Dhingra, S. Sharma, M. Parle, and R.K. Harna Hypolipidemic and weight reducing activity of the ethanolic extract of Tamarindus indica fruit pulp in cafeteria diet- and sulpiride-induced obese rats J Pharmacol Pharmacother 2 2 2011 80 84
87. P.R. Johnson, and J. Hirsch Cellularity of adipose depots in six strains of genetically obese mice J Lipid Res 13 1 1972 2 11
88. H.B. Jones, D. Nugent, and R. Jenkins Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains Int J Exp Pathol 91 3 2010 288 301
89. R. Kahn, J. Buse, E. Ferrannini, and M. Stern The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 28 9 2005 2289 2304
90. M. Kaihara, Y. Nakamura, T. Sugimoto, H.A. Uchida, H. Norii, and Y. Hanayama Olmesartan and temocapril prevented the development of hyperglycemia and the deterioration of pancreatic islet morphology in Otsuka-Long-Evans- Tokushima Fatty rats Acta Med Okayama 63 1 2009 35 42
91. A.J. Kastin, W. Pan, L.M. Maness, R.J. Koletsky, and P. Ernsberger Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor Peptides 20 12 1999 1449 1453
92. K. Kawano, T. Hirashima, S. Mori, Y. Saitoh, M. Kurosumi, and T. Natori Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain Diabetes 41 11 1992 1422 1428
93. T. Kawasaki, K. Igarashi, T. Koeda, K. Sugimoto, K. Nakagawa, and S. Hayashi Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis J Nutr 139 11 2009 2067 2071
94. M. Kern, T.A. Loomis, E.B. Tapscott, and G.L. Dohm Increased muscle glucose uptake in response to chronic glyburide treatment is not related to changes in glucose transporter (GLUT4) protein Int J Biochem 25 9 1993 1257 1261
95. T. Khan, M.P. Hamilton, D.I. Mundy, S.C. Chua, and P.E. Scherer Impact of simvastatin on adipose tissue: pleiotropic effects in vivo Endocrinology 150 12 2009 5262 5272
96. T.J. Kieffer, and J.F. Habener The adipoinsular axis: effects of leptin on pancreatic beta-cells Am J Physiol Endocrinol Metab 278 1 2000 E1 E14
97. M.L. Klebig, J.E. Wilkinson, J.G. Geisler, and R.P. Woychik Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur Proc Natl Acad Sci U S A 92 11 1995 4728 4732
98. K. Kobayashi, T.M. Forte, S. Taniguchi, B.Y. Ishida, K. Oka, and L. Chan The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding Metabolism 49 1 2000 22 31
99. S. Koletsky Obese spontaneously hypertensive rats - a model for study of atherosclerosis Exp Mol Pathol 19 1 1973 53 60
100. S. Koletsky Obese spontaneously hypertensive rats - a model for study of atherosclerosis Exp Mol Pathol 19 1 1973 53 60
101. S. Koletsky Animal model: obese hypertensive rat Am J Pathol 81 2 1975 463 466
102. S. Koletsky Pathologic findings and laboratory data in a new strain of obese hypertensive rats Am J Pathol 80 1 1975 129 142
103. S. Koletsky, and D.I. Puterman Effect of low calorie diet on the hyperlipidemia, hypertension, and life span of genetically obese rats Proc Soc Exp Biol Med 151 2 1976 368 371
104. L. Koranyi, D. James, M. Mueckler, and M.A. Permutt Glucose transporter levels in spontaneously obese (db/db) insulin-resistant mice J Clin Invest 85 3 1990 962 967
105. I. Kosegawa, S. Chen, T. Awata, K. Negishi, and S. Katayama Troglitazone and metformin, but not glibenclamide, decrease blood pressure in Otsuka Long Evans Tokushima Fatty rats Clin Exp Hypertens 21 3 1999 199 211
106. I. Kosegawa, S. Katayama, C. Kikuchi, H. Kashiwabara, K. Negishi, and J. Ishii Metformin decreases blood pressure and obesity in OLETF rats via improvement of insulin resistance Hypertens Res 19 1 1996 37 41
107. P. Kovacs, B. Voigt, S. Berg, L. Vogt, and I. Kloting WOK.1W rats. A potential animal model of the insulin resistance syndrome Ann N Y Acad Sci 827 1997 94 99
108. H.M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, and J. Tuomilehto The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 21 2002 2709 2716
109. P.J. Larsen, E.M. Wulff, C.F. Gotfredsen, C.L. Brand, J. Sturis, and N. Vrang Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats Diabetes Obes Metab 10 4 2008 301 311
110. G.H. Lee, R. Proenca, J.M. Montez, K.M. Carroll, J.G. Darvishzadeh, and J.I. Lee Abnormal splicing of the leptin receptor in diabetic mice Nature 379 6566 1996 632 635
111. J.M. Lenhard, D.K. Croom, and D.T. Minnick Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments Biochem Biophys Res Commun 324 1 2004 92 97
112. H.Z. Lin, S.Q. Yang, C. Chuckaree, F. Kuhajda, G. Ronnet, and A.M. Diehl Metformin reverses fatty liver disease in obese, leptin-deficient mice Nat Med 6 9 2000 998 1003
113. L. Llacuna, A. Fernandez, C.V. Montfort, N. Matias, L. Martinez, and F. Caballero Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury J Hepatol 54 5 2011 1002 1010
114. K. Maedler, F.T. Schulthess, C. Bielman, T. Berney, C. Bonny, and M. Prentki Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases FASEB J 22 6 2008 1905 1913
115. R. Mangat, S. Warnakula, Y. Wang, J.C. Russell, R. Uwiera, and D.F. Vine Model of intestinal chylomicron over-production and ezetimibe treatment: impact on the retention of cholesterol in arterial vessels Atheroscler Suppl 11 1 2010 17 24
116. R.N. Margolis Hepatic glycogen synthase phosphatase and phosphorylase phosphatase activities are increased in obese (fa/fa) hyperinsulinemic Zucker rats: effects of glyburide administration Life Sci 41 24 1987 2615 2622
117. A.L. Mark, R.A. Shaffer, M.L. Correia, D.A. Morgan, C.D. Sigmund, and W.G. Haynes Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice J Hypertens 17 12 Pt 2 1999 1949 1953
118. S.A. McCune, P.B. Baker, and H.F. Stills SHHF/Mcc-cp rat: model of obesity, non insulin-dependent diabetes, and congestive heart failure ILAR News 32 1990 23 27
119. J.D. McKendrick, E. Salas, G.P. Dube, J. Murat, J.C. Russell, and M.W. Radomski Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats Br J Pharmacol 124 2 1998 361 369
120. C. Metais, F. Forcheron, P. Abdallah, A. Basset, P. Del Carmine, and G. Bricca Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin Metabolism 57 7 2008 946 953
121. E.J. Michaud, S.J. Bultman, M.L. Klebig, M.J. van Vugt, L.J. Stubbs, and L.B. Russell A molecular model for the genetic and phenotypic characteristics of the mouse lethal yellow (Ay) mutation Proc Natl Acad Sci U S A 91 7 1994 2562 2566
122. E.J. Michaud, S.J. Bultman, L.J. Stubbs, and R.P. Woychik The embryonic lethality of homozygous lethal yellow mice (Ay/Ay) is associated with the disruption of a novel RNA-binding protein Genes Dev 7 7A 1993 1203 1213
123. M.W. Miller, D.M. Duhl, H. Vrieling, S.P. Cordes, M.M. Ollmann, and B.M. Winkes Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation Genes Dev 7 3 1993 454 467
124. T.M. Mizuno, S.P. Kleopoulos, H.T. Bergen, J.L. Roberts, C.A. Priest, and C.V. Mobbs Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin Diabetes 47 2 1998 294 297
125. T.H. Moran, and S. Bi Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors Philos Trans R Soc Lond B Biol Sci 361 1471 2006 1211 1218
126. Y. Mori, Y. Kitahara, K. Miura, T. Mine, and N. Tajima Role of early insulin secretion in postglucose-loading hyperglycaemia and postfat-loading hyperlipidaemia: comparing nateglinide and glibenclamide for acute effects on insulin secretion in OLETF rats Diabetes Obes Metab 6 6 2004 422 431
127. Y. Mori, F. Oana, A. Matsuzawa, S. Akahane, and N. Tajima Short-term effect of bezafibrate on the expression of adiponectin mRNA in the adipose tissues: a study in spontaneously type 2 diabetic rats with visceral obesity Endocrine 25 3 2004 247 251
128. Y. Mori, K. Ojima, Y. Fuujimori, I. Aoyagi, H. Kusama, and Y. Yamazaki Effects of mitiglinide on glucose-induced insulin release into the portal vein and fat-induced triglyceride elevation in prediabetic and diabetic OLETF rats Endocrine 29 2 2006 309 315
129. M. Naim, J.G. Brand, M.R. Kare, and R.G. Carpenter Energy intake, weight gain and fat deposition in rats fed flavored, nutritionally controlled diets in a multichoice ("cafeteria") design J Nutr 115 11 1985 1447 1458
130. S. Nakano, Y. Inada, H. Masuzaki, T. Tanaka, S. Yasue, and T. Ishii Bezafibrate regulates the expression and enzyme activity of 11beta- hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes Am J Physiol Endocrinol Metab 292 4 2007 E1213 E1222
131. P.M. Nishina, S. Lowe, J. Wang, and B. Paigen Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow Metabolism 43 5 1994 549 553
132. K.S. Oh, E.Y. Kim, M. Yoon, and C.M. Lee Swim training improves leptin receptor deficiency-induced obesity and lipid disorder by activating uncoupling proteins Exp Mol Med 39 3 2007 385 394
133. P. Olivier, M.O. Plancke, D. Marzin, V. Clavey, J. Sauzieres, and J.C. Fruchart Effects of fenofibrate, gemfibrozil and nicotinic acid on plasma lipoprotein levels in normal and hyperlipidemic mice. A proposed model for drug screening Atherosclerosis 70 1-2 1988 107 114
134. C.L. Oltman, E.P. Davidson, L.J. Coppey, T.L. Kleinschmidt, D.D. Lund, and E.T. Adebara Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse Diabetes Obes Metab 10 1 2008 64 74
135. C.L. Oltman, E.P. Davidson, L.J. Coppey, T.L. Kleinschmidt, D.D. Lund, and M.A. Yorek Attenuation of vascular/neural dysfunction in Zucker rats treated with enalapril or rosuvastatin Obesity (Silver Spring) 16 1 2008 82 89
136. C.L. Oltman, T.L. Kleinschmidt, E.P. Davidson, L.J. Coppey, D.D. Lund, and M.A. Yorek Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes Vascul Pharmacol 48 1 2008 47 53
137. J.M. Osmond, J.D. Mintz, and D.W. Stepp Preventing increased blood pressure in the obese Zucker rat improves severity of stroke Am J Physiol Heart Circ Physiol 299 1 2010 H55 H61
138. M. Otani, M. Yamamoto, M. Harada, and M. Otsuki Effect of long- and short-term treatments with pravastatin on diabetes mellitus and pancreatic fibrosis in the Otsuka-Long-Evans-Tokushima fatty rat Br J Pharmacol 159 2 2010 462 473
139. M. Otsuki, T. Akiyama, H. Shirohara, S. Nakano, K. Furumi, and I. Tachibana Loss of sensitivity to cholecystokinin stimulation of isolated pancreatic acini from genetically diabetic rats Am J Physiol 268 3 Pt 1 1995 E531 E536
140. J.M. Overton, T.D. Williams, J.B. Chambers, and M.E. Rashotte Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats Am J Physiol Regul Integr Comp Physiol 280 4 2001 R1007 R1015
141. S.K. Panchal, and L. Brown Rodent models for metabolic syndrome research J Biomed Biotechnol 2011 2011 351982
142. S.C. Park, M.J. Radin, T. Hoepf, and S.A. McCune Comparison of verapamil and felodipine treatment on lipid and glucose metabolism in obese female SHHF/Mcc-facp rats Proc Soc Exp Biol Med 221 3 1999 224 233
143. R.G. Peterson, W.N. Shaw, M.-A. Neel, L.A. Little, and J. Eichberg Zucker Diabetic Fatty rat as a model for non-insulin-dependent diabetes mellitus ILAR J 32 3 1990 16 19
144. M.J. Radin, Y.Y. Chu, T.M. Hoepf, and S.A. McCune Treatment of obese female and male SHHF/Mcc-fa(cp) rats with antihypertensive drugs, nifedipine and enalapril: effects on body weight, fat distribution, insulin resistance and systolic pressure Obes Res 1 6 1993 433 442
145. M.J. Radin, J.E. Jenkins, S.A. McCune, R.R. Jurin, and R.L. Hamlin Effects of enalapril and clonidine on glomerular structure, function, and atrial natriuretic peptide receptors in SHHF/Mcc-cp rats J Cardiovasc Pharmacol 19 3 1992 464 472
146. K. Rahmouni, and W.G. Haynes Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins Bioessays 23 12 2001 1095 1099
147. K. Rahmouni, W.G. Haynes, D.A. Morgan, and A.L. Mark Selective resistance to central neural administration of leptin in agouti obese mice Hypertension 39 2 Pt 2 2002 486 490
148. G.M. Reaven Banting lecture 1988. Role of insulin resistance in human disease Diabetes 37 12 1988 1595 1607
149. M. Richardson, A.M. Schmidt, S.E. Graham, B. Achen, M. DeReske, and J.C. Russell Vasculopathy and insulin resistance in the JCR:LA-cp rat Atherosclerosis 138 1 1998 135 146
150. M. Rossmeisl, J.S. Rim, R.A. Koza, and L.P. Kozak Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity Diabetes 52 8 2003 1958 1966
151. N.J. Rothwell, M.J. Stock, and B.P. Warwick Energy balance and brown fat activity in rats fed cafeteria diets or high-fat, semisynthetic diets at several levels of intake Metabolism 34 5 1985 474 480
152. J.C. Russel, and D. G., K. Jcr:LA-corpulent Rat: A strain with spontaneous vascular and myocardial disease ILAR J 32 3 1990
153. J.C. Russell, D.G. Koeslag, V. Manickavel, R.M. Amy, and P.J. Dolphin Effects of advancing age and severe food restriction on pathological processes in the insulin resistant JCR:LA-corpulent rat Diabetes Res 15 2 1990 53 62
154. J.C. Russell, R.M. Amy, V. Manickavel, and P.J. Dolphin Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat Arteriosclerosis 9 1 1989 122 128
155. J.C. Russell, P.J. Dolphin, S.E. Graham, and R.M. Amy Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA-cp rat J Cardiovasc Pharmacol 29 5 1997 586 592
156. J.C. Russell, S. Graham, and M. Hameed Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat Metabolism 43 5 1994 538 543
157. J.C. Russell, S.E. Graham, B. Stewart, and P.J. Dolphin Sexual dimorphism in the metabolic response to the calcium channel antagonists, diltiazem and clentiazem, by hyperlipidemic JCR:LA-cp rats Biochim Biophys Acta 1258 2 1995 199 205
158. J.C. Russell, S.E. Kelly, A. Diane, Y. Wang, R. Mangat, and S. Novak Rimonabant-mediated changes in intestinal lipid metabolism and improved renal vascular dysfunction in the JCR:LA-cp rat model of prediabetic metabolic syndrome Am J Physiol Gastrointest Liver Physiol 299 2 2010 G507 G516
159. J.C. Russell, D.G. Koeslag, R.M. Amy, and P.J. Dolphin Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats Arteriosclerosis 9 6 1989 869 876
160. I. Sahin, S. Aydin, Y. Ozkan, A.F. Dagli, K.O. Akin, and S.P. Guzel Diet-induced obesity suppresses ghrelin in rat gastrointestinal tract and serum Mol Cell Biochem 355 1-2 2011 299 308
161. Y. Saitoh, T. Tani, Y. Asahi, Z. Man, K. Kawano, and H. Ikunaga Improving effect of carteolol on bodyweight and carbohydrate and lipid metabolic responses in the OLETF rat Clin Exp Pharmacol Physiol 24 5 1997 321 325
162. R. Saladin, P. De Vos, M. Guerre-Millo, A. Leturque, J. Girard, and B. Staels Transient increase in obese gene expression after food intake or insulin administration Nature 377 6549 1995 527 529
163. D.M. Salmon, and D.A. Hems Plasma lipoproteins and the synthesis and turnover of plasma triglyceride in normal and genetically obese mice Biochem J 136 3 1973 551 563
164. B.P. Sampey, A.M. Vanhoose, H.M. Winfield, A.J. Freemerman, M.J. Muehlbauer, and P.T. Fueger Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet Obesity (Silver Spring) 19 6 2011 1109 1117
165. E.H. Schlenker, C.K. Kost Jr., and M.M. Likness Effects of long-term captopril and l-arginine treatment on ventilation and blood pressure in obese male SHHF rats J Appl Physiol 97 3 2004 1032 1039
166. E.H. Schlenker, T. Tamura, and A.M. Gerdes Gender-specific effects of thyroid hormones on cardiopulmonary function in SHHF rats J Appl Physiol 95 6 2003 2292 2298
167. R.E. Schmidt, D.A. Dorsey, L.N. Beaudet, and R.G. Peterson Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy Am J Pathol 163 1 2003 21 28
168. M.W. Schwartz, R.J. Seeley, L.A. Campfield, P. Burn, and D.G. Baskin Identification of targets of leptin action in rat hypothalamus J Clin Invest 98 5 1996 1101 1106
169. D. Senador, K. Kanakamedala, M.C. Irigoyen, M. Morris, and K.M. Elased Cardiovascular and autonomic phenotype of db/db diabetic mice Exp Physiol 94 6 2009 648 658
170. H. Shimizu, T. Tsuchiya, K. Ohtani, K. Shimomura, I.S. Oh, and Y. Ariyama Glucagon plays an important role in the modification of insulin secretion by leptin Islets 3 4 2011 150 154
171. M. Shimoda, Y. Kanda, S. Hamamoto, K. Tawaramoto, M. Hashiramoto, and M. Matsuki The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes Diabetologia 54 5 2011 1098 1108
172. A. Silvani, S. Bastianini, C. Berteotti, C. Franzini, P. Lenzi, and V. Lo Martire Sleep modulates hypertension in leptin-deficient obese mice Hypertension 53 2 2009 251 255
173. D.L. Silver, X.C. Jiang, and A.R. Tall Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover J Biol Chem 274 7 1999 4140 4146
174. F.M. Souza-Smith, P.S. Katz, A.J. Trask, J.A. Stewart Jr., K.C. Lord, and K.J. Varner Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling PLoS One 6 8 2011 e23337
175. D. Spanswick, M.A. Smith, V.E. Groppi, S.D. Logan, and M.L. Ashford Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels Nature 390 6659 1997 521 525
176. S. Sreenan, J. Sturis, W. Pugh, C.F. Burant, and K.S. Polonsky Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone Am J Physiol 271 4 Pt 1 1996 E742 E747
177. O. Stark, I. Kloting, K. Reiher, and K.D. Kohnert The major histocompatibility complex and insulin-dependent diabetes in BB rats Acta Biol Med Ger 41 12 1982 1129 1133
178. L. Ste Marie, G.I. Miura, D.J. Marsh, K. Yagaloff, and R.D. Palmiter A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors Proc Natl Acad Sci U S A 97 22 2000 12339 12344
179. T.W. Stephens, M. Basinski, P.K. Bristow, J.M. Bue-Valleskey, S.G. Burgett, and L. Craft The role of neuropeptide Y in the antiobesity action of the obese gene product Nature 377 6549 1995 530 532
180. J. Sugatani, M. Osabe, T. Wada, K. Yamakawa, Y. Yamazaki, and T. Takahashi Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet Eur J Nutr 47 4 2008 192 200
181. R.S. Surwit, M.N. Feinglos, J. Rodin, A. Sutherland, A.E. Petro, and E.C. Opara Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice Metabolism 44 5 1995 645 651
182. M. Suzuki, D. Shindo, M. Kimura, and H. Waki Effects of exercise, diet, and their combination on metabolic-syndrome-related parameters in OLETF rats Int J Sport Nutr Exerc Metab 21 3 2011 222 232
183. I. Tabbi-Anneni, J. Buchanan, R.C. Cooksey, and E.D. Abel Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts Endocrinology 149 8 2008 4043 4050
184. K. Takaya, Y. Ogawa, J. Hiraoka, K. Hosoda, Y. Yamori, and K. Nakao Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat Nat Genet 14 2 1996 130 131
185. K. Takaya, Y. Ogawa, N. Isse, T. Okazaki, N. Satoh, and H. Masuzaki Molecular cloning of rat leptin receptor isoform complementary DNAs - identification of a missense mutation in Zucker fatty (fa/fa) rats Biochem Biophys Res Commun 225 1 1996 75 83
186. S. Takiguchi, Y. Takata, A. Funakoshi, K. Miyasaka, K. Kataoka, and Y. Fujimura Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats Gene 197 1-2 1997 169 175
187. Y. Tamura, T. Murayama, M. Minami, M. Yokode, and H. Arai Differential effect of statins on diabetic nephropathy in db/db mice Int J Mol Med 28 5 2011 683 687
188. E. Tan, A. Butkus, and S. Koletsky Hepatic cholesterol metabolism in vitro in the obese spontaneously hypertensive, hyperlipemic and atherosclerotic rat Exp Mol Pathol 25 2 1976 142 151
189. J. Tanabe, N. Tamasawa, M. Yamashita, K. Matsuki, H. Murakami, and J. Matsui Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat Diabetes Obes Metab 10 9 2008 772 779
190. T. Tang, and M.J. Reed Exercise adds to metformin and acarbose efficacy in db/db mice Metabolism 50 9 2001 1049 1053
191. X. Tang, Y. Wang, X. Guo, S. Wang, L. Chai, and Y. Zhang Effects of glucagon like peptide-1 treatment on the alveolar capillary basal lamina in Otsuka Long-Evans Tokushima Fatty rats Beijing Da Xue Xue Bao 40 2 2008 178 180
192. L.A. Tartaglia The leptin receptor J Biol Chem 272 10 1997 6093 6096
193. L.A. Tartaglia, M. Dembski, X. Weng, N. Deng, J. Culpepper, and R. Devos Identification and expression cloning of a leptin receptor, OB-R Cell 83 7 1995 1263 1271
194. J. Toblli, G. Cao, C. Rivas, M. Munoz, J. Giani, and F. Dominici Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats J Hypertens 28 5 2010 1007 1019
195. J.E. Toblli, G. DeRosa, C. Rivas, G. Cao, P. Piorno, and P. Pagano Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats J Hypertens 21 3 2003 611 620
196. S.P. Tofovic, R.K. Dubey, and E.K. Jackson 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats J Pharmacol Exp Ther 299 3 2001 973 977
197. S.P. Tofovic, and E.K. Jackson Rat models of the metabolic syndrome Methods Mol Med 86 2003 29 46
198. S.P. Tofovic, H. Kusaka, C.K. Kost Jr., and S. Bastacky Renal function and structure in diabetic, hypertensive, obese ZDF × SHHF-hybrid rats Ren Fail 22 4 2000 387 406
199. V. Trak-Smayra, V. Paradis, J. Massart, S. Nasser, V. Jebara, and B. Fromenty Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet Int J Exp Pathol 92 6 2011 413 421
200. J. van den Brandt, P. Kovacs, and I. Kloting Features of the metabolic syndrome in the spontaneously hypertriglyceridemic Wistar Ottawa Karlsburg W (RT1u Haplotype) rat Metabolism 49 9 2000 1140 1144
201. H. Wang, L.H. Storlien, and X.F. Huang Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression Am J Physiol Endocrinol Metab 282 6 2002 E1352 E1359
202. M.Y. Wang, Y.T. Zhou, C.B. Newgard, and R.H. Unger A novel leptin receptor isoform in rat FEBS Lett 392 2 1996 87 90
203. T.C. Wascher, G. Wolkart, J.C. Russell, and F. Brunner Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats Diabetes 49 5 2000 803 809
204. A. Whaley-Connell, V.G. DeMarco, G. Lastra, C. Manrique, R. Nistala, and S.A. Cooper Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury Am J Nephrol 28 1 2008 67 75
205. D.W. White, D.W. Wang, S.C. Chua Jr., J.P. Morgenstern, R.L. Leibel, and H. Baumann Constitutive and impaired signaling of leptin receptors containing the Gln → Pro extracellular domain fatty mutation Proc Natl Acad Sci U S A 94 20 1997 10657 10662
206. R.N. Willette, N. Aiyar, T.L. Yue, M.P. Mitchell, J. Disa, and B.L. Storer In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats J Pharmacol Exp Ther 289 1 1999 48 53
207. F.E. Yakubu-Madus, W.T. Johnson, K.M. Zimmerman, J. Dananberg, and M.I. Steinberg Metabolic and hemodynamic effects of moxonidine in the Zucker diabetic fatty rat model of type 2 diabetes Diabetes 48 5 1999 1093 1100
208. E. Yamamoto, T. Nakamura, K. Kataoka, Y. Tokutomi, Y.F. Dong, and M. Fukuda Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation Biochem Biophys Res Commun 403 3-4 2010 258 263
209. T. Yamashita, T. Murakami, M. Iida, M. Kuwajima, and K. Shima Leptin receptor of Zucker fatty rat performs reduced signal transduction Diabetes 46 6 1997 1077 1080
210. S.J. Yang, J.M. Choi, L. Kim, B.J. Kim, J.H. Sohn, and W.J. Kim Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes Biochem Biophys Res Commun 407 1 2011 153 157
211. T.T. Yen, W.N. Shaw, and P.L. Yu Genetics of obesity of Zucker rats and Koletsky rats Heredity 38 3 1977 373 377
212. S. Yoshida, T. Ohishi, T. Matsui, H. Tanaka, H. Oshima, and Y. Yonetoku Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice Biochem Biophys Res Commun 402 2 2010 280 285
213. A.A. Young, B.R. Gedulin, S. Bhavsar, N. Bodkin, C. Jodka, and B. Hansen Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta) Diabetes 48 5 1999 1026 1034
214. Y. Yu, K. Ohmori, Y. Chen, C. Sato, H. Kiyomoto, and K. Shinomiya Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model J Am Coll Cardiol 44 4 2004 904 913
215. I. Zavaroni, L. Bonini, M. Fantuzzi, E. Dall'Aglio, M. Passeri, and G.M. Reaven Hyperinsulinaemia, obesity, and syndrome X J Intern Med 235 1 1994 51 56
216. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 6505 1994 425 432
217. L.M. Zucker Hereditary obesity in the rat associated with hyperlipemia Ann N Y Acad Sci 131 1 1965 447 458
218. L.M. Zucker, and T.F. Zucker Fatty, a new mutation in the rat J Hered 52 1961 275